Globalization Of The Pharmaceutical Industry - Pharma

Relevant Publications

(N-NITROSO) PROPAFENONE INDUCED ADVANCED NODULAR MELANOMA-FIRST REPORTED CASE IN THE WORLD LITERATURE: THE INEXTRICABLE LINKS BETWEEN THE PHOTOCARCINOGENESIS, DRUG RELATED NITROSOGENESIS AND PHARMACO-ONCOGENESIS.

Issue Release: 2024

Registering transparency: the making of the international clinical trial registry platform by the world health organization (2004-2006).

Issue Release: 2023

Balancing the risks and benefits of antibiotic use in a globalized world: the ethics of antimicrobial resistance.

Issue Release: 2023

NITROSOGENESIS OF SKIN (HUMAN) CANCER- THE HIDDEN TRUTH OF A NEVERENDING STORY: NITROSAMINE CONTAMINATION IN OLMESARTAN, VALSARTAN AND HCT AS MAIN RISK FACTOR FOR THE DEVELOPMENT OF KERATINOCYTE CANCER.

Issue Release: 2023

[The development of regulation of medications turn-over in the EU and the USA in 1992-2020. Report I. The formation of normative legal base of pharmaceutical activities in the USA].

Issue Release: 2023

The link Between Stock Exchange Sectors and Indices: Implications During the COVID-19 Pandemic.

Issue Release: 2022

The Effect of Organizational Resilience and Strategic Foresight on Firm Performance: Competitive Advantage as Mediating Variable.

Issue Release: 2021

Understanding Quality Paradigm Shifts in the Evolving Pharmaceutical Landscape: Perspectives from the USP Quality Advisory Group.

Issue Release: 2021

Elements of Regulatory Dissonance: Examining FDA and EMA Product Labeling of New Vaccines (2006-2018).

Issue Release: 2020

Cost-effectiveness and resource allocation (CERA) 18 years of evolution: maturity of adulthood and promise beyond tomorrow.

Issue Release: 2020

Clinical trials sponsored by industry and other private organizations.

Issue Release: 2020

[Drug turnover in the Russian Federation: customs aspect].

Issue Release: 2020

Characteristics of Industry-Sponsored Drug Clinical Trials Registered in Japan Pharmaceutical Information Center Clinical Trials Information 2010-2018.

Issue Release: 2020

Medicines for Europe - 13th Pharmacovigilance Conference (January 29, 2020 - Amsterdam, the Netherlands).

Issue Release: 2020

What is the impact of patient recruitment on offshoring of clinical trials?

Issue Release: 2020

How Does \"Regulatory Practice\" Create Discrepancies in Drug Label Information Between Asian and Western Countries? Different Label Information for Direct Oral Anticoagulants Approved in the United States, Europe, Korea, and Japan.

Issue Release: 2018

Transnational pharmacogovernance: emergent patterns in the jazz of pharmaceutical policy convergence.

Issue Release: 2018

Strategic inclusion of regions in multiregional clinical trials.

Issue Release: 2018

Exploratory Analysis of Associations Between Postmarketing Safety Events and Approved Doses of New Drugs in Japan.

Issue Release: 2017

Regional Differences During the ICH Regulatory Consultation Process Between the EU, US, and Japan.

Issue Release: 2017

What Should Be Included in Patient Education Materials?

How Does Pharma Play a Role in Chronic Conditions?

Who are Pharmacists?

How Long Does the Approval Process Take?

Why do Pharma Companies Use CROs?

What is Geriatric Care in Pharma?

How are ADEs Different from Side Effects?

What is Medication Adherence?

What is the Future of Patient Education in Pharma?

What are the Regulatory Requirements for Generic Drugs?

Globalization Of The Pharmaceutical Industry - Pharma

Relevant Publications

Partnered Content Networks

Relevant Topics